Thymosin Alpha-1 is an immune-modulating compound that is formally approved as a pharmaceutical product in more than 30 countries including Italy, China, and several Southeast Asian nations for the treatment of hepatitis B, hepatitis C, and as an immune adjuvant in oncology
Studies have shown a link between low vitamin B12 levels and osteoporosis
Research shows BPC-157 treatment accelerates healing of transected tendons through promotion of tendon outgrowth, cell survival, and cell migration via regulation of ERK1/2 phosphorylation and downstream targets including c-Fos, c-Jun, and Egr-1key molecules involved in cell growth, migration, and angiogenesis
Currently, Klow Blend is being investigated for potential applications in soft tissue regeneration studies, inflammation signaling research, cellular migration models, and recovery pathways associated with tissue stress or injury